Navigation Links
PDL BioPharma Announces 2013 Regular Quarterly Dividends
Date:1/30/2013

INCLINE VILLAGE, Nev., Jan. 30, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that its board of directors has declared that the regular, quarterly dividends to be paid to its stockholders in 2013 will be $0.15 per share of common stock.  The $0.15 dividends will each be paid on March 12, June 12, September 12 and December 12 of 2013 to all stockholders who own shares of PDL on March 5, June 5, September 5 and December 5 of 2013, the record dates for each of the dividend payments, respectively.

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

"We are pleased to announce that we will pay regular quarterly dividends for 2013 to our shareholders totaling $0.60 per share for the year," said John P. McLaughlin , president and chief executive officer of PDL BioPharma. "This will be the fifth consecutive year that PDL has paid either a special or regular dividend and the third consecutive year that it will pay a regular dividend."

Stockholders desiring to purchase shares with rights to the dividend must ensure that their trades are executed prior to the "ex-dividend" date and settle prior to the record date. NASDAQ will establish an ex-dividend date that is generally two business days prior to the record date. Investors should consult with their brokers or financial advisors regarding their specific situations.

About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing value for its shareholders. For more information, please
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ANDOVER, Massachusetts y LONDRES, 28 de ... PHG, AEX: PHIA) anunció hoy su participación en ... donde exhibirá sus soluciones cardiológicas más recientes y ... IntelliSpace Cardiovascular, que conectan a las personas y ... forma de ayudar a diagnosticar, guiar los tratamientos ...
(Date:8/27/2015)... Calif. , Aug. 27, 2015 DURECT ... is scheduled to present at three upcoming healthcare conferences.  ... President and CEO, will present at the Rodman & ... a.m. Eastern time. The conference is being held at ... City . A live audio webcast of the ...
(Date:8/27/2015)... Aug. 27, 2015  Now that Intuitive Surgical, Inc.® ... S™ surgical robot, hospitals with robotic surgery programs need ... need to see where they stand with robotic surgery. ... patients? Have they adopted best practices for safety? Should ... the future? ECRI Institute, which has nearly ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... SILVER SPRING, Md., April 9, 2012 Sunpeaks Ventures, ... SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned ... that HDS has signed a Letter of Intent with PharmaLife ... pharmacies in the Russian Federation.    The Letter ...
... -- Global Information, Inc. is excited to announce remaining available ... for Boston, MA in the Spring of 2012. ... Design Conference June 6 - 8, ... arrive at its current mainstream position in medicinal chemistry, and ...
Cached Medicine Technology:Sunpeaks Ventures Announces Letter of Intent to Export Clotamin to Top Russian Pharmacies 2Sunpeaks Ventures Announces Letter of Intent to Export Clotamin to Top Russian Pharmacies 3Boston to Host 3 Major Annual Drug Discovery Conferences, Early Bird Expiring April 27 2Boston to Host 3 Major Annual Drug Discovery Conferences, Early Bird Expiring April 27 3
(Date:8/29/2015)... Calgary, AB (PRWEB) , ... August 29, 2015 ... ... congestive heart failure, angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are ... conditions such as angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing number ... recently transitioned management companies to partner with Wound Care Advantage (WCA) to utilize ... center. , Transitioning wound care management providers can be a complex undertaking. ...
(Date:8/28/2015)... ... ... With the goal of furthering music education programs in schools, the “Music ... Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best Drug ... underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best Drug ...
(Date:8/28/2015)... , ... August 28, 2015 , ... On May 30th, ... joined as sponsor of the “Music With A Mission” benefit concert in Mendon, IL. ... event was to raise money to support music education programs in the underfunded local ...
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs and alcohol abuse ... gives a new approach on solutions in his new book ":Unraveling The Psychological ... employees getting together for meaningful group meetings. "This would educate the employees on ...
Breaking Medicine News(10 mins):Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... (ZealousPR) Award-winning Vanity,Fair writer and hospice volunteer, Judy Bachrach, ... on dying well,", http://www.TheCheckoutLine.org -- the first online ... them, today. Every Monday, Wednesday and,Friday, beginning May 21, ... for anyone needing help on the most critical part ...
... particularly to barns and farm milk, while pregnant confer ... group of German researchers, who will present their findings ... Toronto on Wednesday, May 21., In a study of ... mothers, the researchers believe they have proved their hypothesis ...
... ANN ARBOR, Mich. For people with diabetes, high blood pressure ... and kidney problems. , But a new study finds that ... with a high blood pressure reading, theres only a 50-50 chance ... it. That might mean a change to their medications, or a ...
... May 19 Volcano Corporation,(Nasdaq: VOLC ), ... and Optical Coherence Tomography (OCT) products designed,to enhance ... vascular,disease, said today that it will be participating ... Tuesday, May 20., The presentation by Scott ...
... procedure performed by Dr. Robert S. Bray, Jr. of ... D.I.S.C. Spine ... Roach is living,her dream after successfully qualifying for the 2008 ... one of the country,s preeminent,neurological spinal surgeons specializing in micro ...
... LLC, the world,s,first mobile voice-activation solution for e-Health ... J. Zecchini as its Chief,Operating Officer and Chief ... be responsible for all operations and technology functions., ... to our MediVoice team," said,Anthony V. Milone, Board ...
Cached Medicine News:Health News:Award Winning Vanity Fair Contributing Editor Judy Bachrach Launches 'TheCheckoutLine.org - An Advice Column on Dying Well' 2Health News:Farm moms may help children beat allergies 2Health News:Study: Doctors not always sure when to treat BP in people with diabetes 2Health News:Study: Doctors not always sure when to treat BP in people with diabetes 3Health News:Study: Doctors not always sure when to treat BP in people with diabetes 4Health News:Volcano Corporation Presentation at JMP Conference to be Webcast 2Health News:Successful Back Surgery Propels Olympic Weightlifting Hopeful Melanie Roach to Realize Her Dreams Of Participating in the 2008 Beijing Olympics 2Health News:MediVoice Announces Appointment of Edward J. Zecchini as Chief Operating Officer & Chief Technology Officer 2
... Orthofix Pelvic Fixator is achieved by means ... and a fixator assembly which consists of ... unit. A supplementary link may be used ... applications. With this new design, the ball-joint ...
For radial/ulnar translation, angulation, dorsal/volar translation, and incremental longitudinal distraction, this advanced system is appropriate when incremental adjustment provides an adjunctive me...
Provides basic reduction capabilities for angulation, rotation and length. Ball joint design offers fracture reduction in all planes....
... Clamps have a slender design contributes to ... of Kirschner wires. The Connecting Clamp allows ... and/or Connecting Bar. Uses 3.0 mm Carbon ... wires eliminate need to predrill and provide ...
Medicine Products: